Eli Lilly and Company (LLY) stock news · P/E 39, rev $22.97B
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
This LLY news page leads with what Eli Lilly and Company filed — not a scraped headline mill.
No cached 8-K sentence for LLY yet. We will not pad this page with generic market recap.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LLY stock page; for the tape open the quote page.
Not investment advice.